Arcturus Therapeutics Holdings (ARCT) Shares Issued (2018 - 2025)
Historic Shares Issued for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to $640000.0.
- Arcturus Therapeutics Holdings' Shares Issued rose 571818.18% to $640000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 7909.17%. This contributed to the annual value of $4.7 million for FY2024, which is 7751.12% up from last year.
- As of Q3 2025, Arcturus Therapeutics Holdings' Shares Issued stood at $640000.0, which was up 571818.18% from $274000.0 recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Shares Issued ranged from a high of $2.4 million in Q2 2024 and a low of $11000.0 during Q3 2024
- For the 5-year period, Arcturus Therapeutics Holdings' Shares Issued averaged around $650058.8, with its median value being $336000.0 (2022).
- In the last 5 years, Arcturus Therapeutics Holdings' Shares Issued tumbled by 9990.51% in 2021 and then skyrocketed by 571818.18% in 2025.
- Arcturus Therapeutics Holdings' Shares Issued (Quarter) stood at $230000.0 in 2021, then skyrocketed by 233.91% to $768000.0 in 2022, then surged by 74.87% to $1.3 million in 2023, then tumbled by 90.02% to $134000.0 in 2024, then soared by 377.61% to $640000.0 in 2025.
- Its Shares Issued stands at $640000.0 for Q3 2025, versus $274000.0 for Q2 2025 and $195000.0 for Q1 2025.